16:8 vs 5:2 vs OMAD: Which Intermittent Fasting Method Actually Works Best?

In this guide

1. The three fasting protocols everyone compares

2. 16:8 — the default most people should start with

3. 5:2 — the protocol with the strongest recent trial data

4. OMAD — the most extreme, and the trade-off nobody mentions

5. Head-to-head: what the direct comparison trials found

6. Why adherence beats protocol choice almost every time

7. The autophagy claim — what's proven and what's marketing

8. Which protocol actually fits your situation

9. Frequently asked questions

Every intermittent fasting conversation eventually collapses into the same three-way debate: 16:8, 5:2, or OMAD? Social media treats this like picking a side in a rivalry, when the actual research paints a considerably less dramatic picture — all three work through the same basic mechanism, and the differences between them matter less than which one you'll actually stick with.

Long-term adherence data shows 16:8 retained at roughly 78% of users after one year, compared to 65% for 5:2 and just 52% for OMAD. Direct comparison trials find broadly similar weight-loss outcomes across all three when total calorie intake is matched — meaning the "best" protocol is overwhelmingly the one that fits your life well enough to actually sustain.

This guide breaks down each protocol individually, what head-to-head trials actually found, and which one is worth starting with based on your specific situation.

The Three Fasting Protocols Everyone Compares

Intermittent fasting cycles between eating and fasting periods rather than restricting specific foods — it changes when you eat, not primarily what you eat, which is what distinguishes it from traditional dieting. The three most-discussed variants differ mainly in how that time restriction is structured across a day or week.

16:8 — The Default Most People Should Start With

The 16:8 method restricts eating to an 8-hour daily window, fasting for the remaining 16 hours — commonly by skipping breakfast and eating between roughly noon and 8pm. It's the most widely practiced protocol, accounting for an estimated 40% of all intermittent fasting practitioners, largely because most people already fast 10-12 hours overnight simply by sleeping; extending that by a few hours feels far less disruptive than the other two protocols.

Research on 16:8 specifically supports its use for both fat loss and muscle retention: a study by Moro and colleagues found resistance-trained men maintained lean mass on a 16:8 schedule while still reducing fat mass, and a widely cited 2020 trial published in JAMA Internal Medicine found 16:8 produced weight loss outcomes broadly comparable to continuous calorie restriction at matched intake.

5:2 — The Protocol With the Strongest Recent Trial Data

The 5:2 method allows normal eating five days a week while restricting intake to roughly 500-600 calories on two non-consecutive days. It gained mainstream credibility through Dr. Michael Mosley's research and BBC documentation, and it has since accumulated some of the strongest recent clinical trial evidence of the three protocols — including large-scale data from China specifically.

A randomized clinical trial of 405 Chinese adults with early type 2 diabetes, published as the EARLY trial, tested an enhanced version — 5:2 combined with meal replacement on fasting days — against standard antidiabetic medications (metformin and empagliflozin) over 16 weeks. The 5:2 meal-replacement approach achieved better glycemic control than either medication, suggesting this protocol may serve as a legitimate first-line lifestyle intervention rather than just a weight-loss tool. A separate pilot study of 131 Chinese adults with overweight or obesity found the "5:2 plus" group lost 9.0% of body weight over 12 weeks — significantly more than a matched daily-calorie-restriction group at 5.7%.

OMAD — The Most Extreme, and the Trade-Off Nobody Mentions

One Meal A Day compresses all eating into a single sitting, fasting for the remaining ~23 hours. It's frequently framed as the most "advanced" or effective protocol, and it does produce meaningful results — a study published in the New England Journal of Medicine found OMAD reduced both blood pressure and body weight. The trade-off that gets far less attention: the same study found OMAD reduced lean muscle mass more than eating the identical total calories across three meals per day, and researchers specifically noted that meeting adequate protein intake (≥1.6g/kg body weight) in a single sitting is nutritionally challenging for most people.

OMAD's aggressive time restriction doesn't just make it harder to sustain — it makes it structurally harder to hit adequate protein and micronutrient targets in one sitting, which is a meaningfully different concern than simple willpower.

Head-to-Head: What the Direct Comparison Trials Found

Trial Comparison	Finding
Alternate-day fasting vs. 16:8 vs. control (101 adults)	Both fasting groups reduced weight, BMI, and waist circumference more than control; alternate-day fasting produced somewhat larger reductions than 16:8
5:2 vs. daily calorie restriction (131 Chinese adults, 12 weeks)	5:2 plus achieved 9.0% weight loss vs. 5.7% for matched daily restriction
5:2 meal-replacement vs. metformin/empagliflozin (405 Chinese adults, 16 weeks)	5:2 approach achieved better HbA1c (blood sugar) control than either medication
16:8 vs. continuous calorie restriction (JAMA Internal Medicine, 2020)	Broadly equivalent fat-loss outcomes at matched calorie intake

The consistent thread across these trials: when total weekly calorie intake is comparable, the specific fasting structure matters less than whether the approach is actually followed consistently. None of the head-to-head data suggests one protocol has a unique metabolic advantage that the others structurally cannot achieve.

Why Adherence Beats Protocol Choice Almost Every Time

This is the finding that should reshape how most people choose between these three options: 16:8's 78% one-year retention rate, against 5:2's 65% and OMAD's 52%, suggests the easier protocol produces better real-world results simply by being sustained longer — even if OMAD theoretically produces a stronger short-term metabolic signal in a controlled trial setting. A protocol you follow consistently for a year outperforms a "more powerful" protocol you abandon after six weeks.

The Autophagy Claim — What's Proven and What's Marketing

Autophagy — the cellular process of breaking down and recycling damaged components — is frequently cited as fasting's key longevity mechanism, often with specific claimed timing thresholds ("autophagy kicks in at 16 hours," "at 24 hours"). This claim deserves more scrutiny than it typically receives. The 2016 Nobel Prize in Physiology or Medicine was awarded to Yoshinori Ohsumi specifically for discovering autophagy's mechanisms — the underlying biology is real and well-established. What's considerably less established is the precise timing claim.

Measuring autophagy directly in living humans remains technically difficult, and the specific hour-based thresholds circulating online are based primarily on animal studies, not direct human measurement. A comprehensive 2019 review in the New England Journal of Medicine by de Cabo and Mattson described the research on intermittent fasting and human health as promising, while explicitly noting that precise autophagy timing in humans is not yet definitively established.

This doesn't mean fasting's benefits are fabricated — weight loss, improved insulin sensitivity, and other measured outcomes across the trials above are real and documented. It means the specific "16-hour autophagy switch" framing common in fasting marketing outpaces what's actually been confirmed in human research.

Which Protocol Actually Fits Your Situation

Your Situation	Best Starting Protocol	Why
New to fasting entirely	16:8	Smallest adjustment from typical overnight fasting; highest sustained adherence
Prefer flexibility over daily structure	5:2	Normal eating five days a week; only two days require real restriction
Managing blood sugar specifically, under medical guidance	5:2 with meal replacement	Strongest current trial evidence for glycemic outcomes specifically
Experienced faster wanting a bigger metabolic push short-term	OMAD, time-limited	Real short-term results, but plan for protein adequacy and don't default to it long-term

Whichever protocol you choose, your total daily and weekly calorie and protein targets still matter — fasting changes the timing, not the underlying energy-balance principles. Use the calorie calculator to set your target, and the protein intake calculator to make sure your eating window — however long it is — still delivers adequate protein.

Frequently Asked Questions

Is 16:8 or OMAD better for fat loss?

Direct comparisons show broadly similar fat-loss outcomes when total calorie intake is matched between protocols. OMAD carries a documented risk of greater lean mass loss compared to spreading the same calories across more meals, making 16:8 or a more moderate protocol preferable for most people prioritising muscle retention.

Which intermittent fasting method has the most scientific support?

16:8 has the largest body of research given its widespread use and study duration, while 5:2 has recently accumulated particularly strong trial data for glycemic control specifically, including a large 405-person Chinese trial outperforming standard diabetes medications. OMAD has real supporting evidence but comes with clearer documented trade-offs around lean mass and nutrient adequacy.

Does fasting really trigger autophagy at 16 hours?

The specific hour-based autophagy thresholds commonly cited are based primarily on animal research; measuring autophagy directly in humans remains technically difficult, and a 2019 New England Journal of Medicine review described human timing data as still not definitively established, despite the broader mechanism being scientifically well-supported.

Can I switch between fasting protocols, or should I pick one and stick with it?

There's no strong evidence that switching protocols is harmful, and some people successfully use different protocols for different life phases (e.g., 16:8 as a daily default, 5:2 during a more focused fat-loss period). Consistency with whichever protocol you're currently following matters more than rigidly committing to one forever.

Is OMAD dangerous?

For most healthy adults, OMAD isn't inherently dangerous, but it does carry documented risks around meeting protein and micronutrient needs in a single meal, and greater lean-mass loss compared to more frequent eating patterns. It's generally not recommended as a starting protocol for people new to fasting.

Do I need to fast every day for intermittent fasting to work?

No — 5:2 specifically demonstrates that only two restricted days per week can produce meaningful, trial-documented results. Daily protocols like 16:8 aren't inherently superior; they simply represent a different structure with their own adherence profile.

---

References & Sources

1. Moro, T. et al. (2016). Effects of eight weeks of time-restricted feeding on body composition and metabolic markers in resistance-trained males. Journal of Translational Medicine, 14, 290.
2. Zhang, L-M. et al. (2024). Effects of intermittent fasting 5:2 plus program on body weight in Chinese adults with overweight or obesity. Nutrients.
3. The EARLY Trial Investigators (2024). A 5:2 intermittent fasting meal replacement diet and glycemic control for adults with diabetes. JAMA Network Open.
4. de Cabo, R. & Mattson, M. P. (2019). Effects of intermittent fasting on health, aging, and disease. New England Journal of Medicine, 381(26), 2541–2551.
5. Stekovic, S. et al. (2019). Alternate day fasting improves physiological and molecular markers of aging in healthy, non-obese humans. Cell Metabolism, 30(3), 462–476.
6. MacrosMeasure (2025). Free Calorie Calculator.
7. MacrosMeasure (2025). Free Protein Intake Calculator.